<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The 35-year-old man with <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) and <z:hpo ids='HP_0001913'>granulocytopenia</z:hpo> with dry cough and high <z:hpo ids='HP_0001945'>fever</z:hpo> was eventually found to have a left perinephric <z:mpath ids='MPATH_612'>abscess</z:mpath> of Staphylococcus aureus </plain></SENT>
<SENT sid="1" pm="."><plain>He underwent left nephrectomy and drainage of perinephric space in conjunction with appropriate antibiotics </plain></SENT>
<SENT sid="2" pm="."><plain>However, because of persistent <z:hpo ids='HP_0001913'>granulocytopenia</z:hpo>, Staph. aureus never cleared up with formation of only poor granulation </plain></SENT>
<SENT sid="3" pm="."><plain>Recombinant human granulocyte colony-stimulating factor (G-CSF) was added to the above treatment leading to prompt improvement in <z:hpo ids='HP_0001913'>granulocytopenia</z:hpo> and emergence of the good <z:mpath ids='MPATH_183'>granulation tissue</z:mpath> </plain></SENT>
<SENT sid="4" pm="."><plain>G-CSF will probably become one of the important agents in treating <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> with <z:hpo ids='HP_0001913'>granulocytopenia</z:hpo> </plain></SENT>
</text></document>